{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:42:33Z","timestamp":1790966553780,"version":"4.1.0"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"22","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Members of the vascular endothelial growth factor (VEGF) family are critical players in angiogenesis and lymphangiogenesis. Although VEGF-A has been shown to exert fundamental functions in physiologic and pathologic angiogenesis, the exact role of the VEGF family member placental growth factor (PlGF) in tumor angiogenesis has remained controversial. To gain insight into PlGF function during tumor angiogenesis, we have generated transgenic mouse lines expressing human PlGF-1 in the \u03b2 cells of the pancreatic islets of Langerhans (Rip1PlGF-1). In single-transgenic Rip1PlGF-1 mice, intra-insular blood vessels are found highly dilated, whereas islet physiology is unaffected. Upon crossing of these mice with the Rip1Tag2 transgenic mouse model of pancreatic \u03b2 cell carcinogenesis, tumors of double-transgenic Rip1Tag2;Rip1PlGF-1 mice display reduced growth due to attenuated tumor angiogenesis. The coexpression of transgenic PlGF-1 and endogenous VEGF-A in the \u03b2 tumor cells of double-transgenic animals causes the formation of low-angiogenic hPlGF-1\/mVEGF-A heterodimers at the expense of highly angiogenic mVEGF-A homodimers resulting in diminished tumor angiogenesis and reduced tumor infiltration by neutrophils, known to contribute to the angiogenic switch in Rip1Tag2 mice. The results indicate that the ratio between the expression levels of two members of the VEGF family of angiogenic factors, PlGF-1 and VEGF-A, determines the overall angiogenic activity and, thus, the extent of tumor angiogenesis and tumor growth. [Cancer Res 2007;67(22):10840\u20138]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-1034","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T15:23:37Z","timestamp":1195140217000},"page":"10840-10848","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Placental Growth Factor-1 Attenuates Vascular Endothelial Growth Factor-A\u2013Dependent Tumor Angiogenesis during \u03b2 Cell Carcinogenesis"],"prefix":"10.1158","volume":"67","author":[{"given":"Tibor","family":"Schomber","sequence":"first","affiliation":[{"name":"1Institute of Biochemistry and Genetics, Department of Clinical-Biological Sciences, University of Basel, Basel, Switzerland and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Kopfstein","sequence":"additional","affiliation":[{"name":"1Institute of Biochemistry and Genetics, Department of Clinical-Biological Sciences, University of Basel, Basel, Switzerland and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Djonov","sequence":"additional","affiliation":[{"name":"2Institute of Anatomy, University of Berne, Berne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke","family":"Albrecht","sequence":"additional","affiliation":[{"name":"1Institute of Biochemistry and Genetics, Department of Clinical-Biological Sciences, University of Basel, Basel, Switzerland and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Baeriswyl","sequence":"additional","affiliation":[{"name":"1Institute of Biochemistry and Genetics, Department of Clinical-Biological Sciences, University of Basel, Basel, Switzerland and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Strittmatter","sequence":"additional","affiliation":[{"name":"1Institute of Biochemistry and Genetics, Department of Clinical-Biological Sciences, University of Basel, Basel, Switzerland and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Christofori","sequence":"additional","affiliation":[{"name":"1Institute of Biochemistry and Genetics, Department of Clinical-Biological Sciences, University of Basel, Basel, Switzerland and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,11,15]]},"reference":[{"key":"2022061623221409800_B1","doi-asserted-by":"crossref","unstructured":"Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature\u20082005; 438: 967\u201374.","DOI":"10.1038\/nature04483"},{"key":"2022061623221409800_B2","doi-asserted-by":"crossref","unstructured":"Ferrara N. VEGF as a therapeutic target in cancer. Oncology\u20082005; 69 Suppl 3: 11\u20136.","DOI":"10.1159\/000088479"},{"key":"2022061623221409800_B3","doi-asserted-by":"crossref","unstructured":"Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol\u20082005; 23: 1011\u201327.","DOI":"10.1200\/JCO.2005.06.081"},{"key":"2022061623221409800_B4","doi-asserted-by":"crossref","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med\u20082003; 9: 669\u201376.","DOI":"10.1038\/nm0603-669"},{"key":"2022061623221409800_B5","doi-asserted-by":"crossref","unstructured":"Shojaei F, Ferrara N. Antiangiogenesis to treat cancer and intraocular neovascular disorders. Lab Invest 2007;87:227\u201330.","DOI":"10.1038\/labinvest.3700526"},{"key":"2022061623221409800_B6","doi-asserted-by":"crossref","unstructured":"Schneider BP, Sledge GWJ. Drug insight: VEGF as a therapeutic target for breast cancer. Nat Clin Pract Oncol\u20082007; 4: 181\u20139.","DOI":"10.1038\/ncponc0740"},{"key":"2022061623221409800_B7","doi-asserted-by":"crossref","unstructured":"Kowanetz M, Ferrara N. Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res\u20082006; 12: 5018\u201322.","DOI":"10.1158\/1078-0432.CCR-06-1520"},{"key":"2022061623221409800_B8","doi-asserted-by":"crossref","unstructured":"Gasparini G, Longo R, Toi M, Ferrara N. Angiogenic inhibitors: a new therapeutic strategy in oncology. Nat Clin Pract Oncol\u20082005; 2: 562\u201377.","DOI":"10.1038\/ncponc0342"},{"key":"2022061623221409800_B9","doi-asserted-by":"crossref","unstructured":"Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res\u20082006; 312: 549\u201360.","DOI":"10.1016\/j.yexcr.2005.11.012"},{"key":"2022061623221409800_B10","doi-asserted-by":"crossref","unstructured":"Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling\u2014in control of vascular function. Nat Rev Mol Cell Biol\u20082006; 7: 359\u201371.","DOI":"10.1038\/nrm1911"},{"key":"2022061623221409800_B11","doi-asserted-by":"crossref","unstructured":"Hauser S, Weich HA. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors\u20081993; 9: 259\u201368.","DOI":"10.3109\/08977199308991586"},{"key":"2022061623221409800_B12","doi-asserted-by":"crossref","unstructured":"Cao Y, Ji WR, Qi P, Rosin A, Cao Y. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem Biophys Res Commun\u20081997; 235: 493\u20138.","DOI":"10.1006\/bbrc.1997.6813"},{"key":"2022061623221409800_B13","unstructured":"Maglione D, Guerriero V, Viglietto G, et al. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene\u20081993; 8: 925\u201331."},{"key":"2022061623221409800_B14","doi-asserted-by":"crossref","unstructured":"Achen MG, Gad JM, Stacker SA, Wilks AF. Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development. Growth Factors\u20081997; 15: 69\u201380.","DOI":"10.3109\/08977199709002113"},{"key":"2022061623221409800_B15","doi-asserted-by":"crossref","unstructured":"Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med\u20082001; 7: 575\u201383.","DOI":"10.1038\/87904"},{"key":"2022061623221409800_B16","doi-asserted-by":"crossref","unstructured":"Luttun A, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med\u20082002; 8: 831\u201340.","DOI":"10.1038\/nm731"},{"key":"2022061623221409800_B17","doi-asserted-by":"crossref","unstructured":"Oura H, Bertoncini J, Velasco P, Brown LF, Carmeliet P, Detmar M. A critical role of placental growth factor in the induction of inflammation and edema formation. Blood\u20082003; 101: 560\u20137.","DOI":"10.1182\/blood-2002-05-1516"},{"key":"2022061623221409800_B18","doi-asserted-by":"crossref","unstructured":"Cianfarani F, Zambruno G, Brogelli L, et al. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am J Pathol\u20082006; 169: 1167\u201382.","DOI":"10.2353\/ajpath.2006.051314"},{"key":"2022061623221409800_B19","doi-asserted-by":"crossref","unstructured":"Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer\u20082002; 2: 826\u201335.","DOI":"10.1038\/nrc925"},{"key":"2022061623221409800_B20","doi-asserted-by":"crossref","unstructured":"Bertolini F, Shaked Y, Mancuso P, Kerbel RS. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer\u20082006; 6: 835\u201345.","DOI":"10.1038\/nrc1971"},{"key":"2022061623221409800_B21","doi-asserted-by":"crossref","unstructured":"Lin EY, Li JF, Gnatovskiy L, et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res\u20082006; 66: 11238\u201346.","DOI":"10.1158\/0008-5472.CAN-06-1278"},{"key":"2022061623221409800_B22","doi-asserted-by":"crossref","unstructured":"Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell\u20082006; 124: 263\u20136.","DOI":"10.1016\/j.cell.2006.01.007"},{"key":"2022061623221409800_B23","doi-asserted-by":"crossref","unstructured":"Parr C, Watkins G, Boulton M, Cai J, Jiang WG. Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur J Cancer\u20082005; 41: 2819\u201327.","DOI":"10.1016\/j.ejca.2005.07.022"},{"key":"2022061623221409800_B24","doi-asserted-by":"crossref","unstructured":"Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG. Expression of placenta growth factor (PlGF) in non\u2013small cell lung cancer (NSCLC) and the clinical and prognostic significance. World J Surg Oncol\u20082005; 3: 68.","DOI":"10.1186\/1477-7819-3-68"},{"key":"2022061623221409800_B25","doi-asserted-by":"crossref","unstructured":"Marcellini M, De Luca N, Riccioni T, et al. Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. Am J Pathol\u20082006; 169: 643\u201354.","DOI":"10.2353\/ajpath.2006.051041"},{"key":"2022061623221409800_B26","doi-asserted-by":"crossref","unstructured":"Luttun A, Tjwa M, Carmeliet P. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Ann N Y Acad Sci\u20082002; 979: 80\u201393.","DOI":"10.1111\/j.1749-6632.2002.tb04870.x"},{"key":"2022061623221409800_B27","doi-asserted-by":"crossref","unstructured":"Eriksson A, Cao R, Pawliuk R, et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1\/VEGF heterodimers. Cancer Cell\u20082002; 1: 99\u2013108.","DOI":"10.1016\/S1535-6108(02)00028-4"},{"key":"2022061623221409800_B28","doi-asserted-by":"crossref","unstructured":"Xu L, Cochran DM, Tong RT, et al. Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models. Cancer Res\u20082006; 66: 3971\u20137.","DOI":"10.1158\/0008-5472.CAN-04-3085"},{"key":"2022061623221409800_B29","doi-asserted-by":"crossref","unstructured":"Hanahan D. Heritable formation of pancreatic \u03b2-cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes. Nature\u20081985; 315: 115\u201322.","DOI":"10.1038\/315115a0"},{"key":"2022061623221409800_B30","doi-asserted-by":"crossref","unstructured":"Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature\u20081989; 339: 58\u201361.","DOI":"10.1038\/339058a0"},{"key":"2022061623221409800_B31","doi-asserted-by":"crossref","unstructured":"Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature\u20081998; 392: 190\u20133.","DOI":"10.1038\/32433"},{"key":"2022061623221409800_B32","doi-asserted-by":"crossref","unstructured":"Inoue M, Hager JH, Ferrara N, Gerber HP, Hanahan D. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic \u03b2 cell carcinogenesis. Cancer Cell\u20082002; 1: 193\u2013202.","DOI":"10.1016\/S1535-6108(02)00031-4"},{"key":"2022061623221409800_B33","doi-asserted-by":"crossref","unstructured":"Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol\u20082000; 2: 737\u201344.","DOI":"10.1038\/35036374"},{"key":"2022061623221409800_B34","unstructured":"Compagni A, Wilgenbus P, Impagnatiello MA, Cotten M, Christofori G. Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res\u20082000; 60: 7163\u20139."},{"key":"2022061623221409800_B35","doi-asserted-by":"crossref","unstructured":"Labosky PA, Barlow DP, Hogan BL. Embryonic germ cell lines and their derivation from mouse primordial germ cells. Ciba Found Symp\u20081994; 182: 157\u201368; discussion 168\u201378.","DOI":"10.1002\/9780470514573.ch9"},{"key":"2022061623221409800_B36","unstructured":"Gannon G, Mandriota SJ, Cui L, Baetens D, Pepper MS, Christofori G. Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during \u03b2-cell carcinogenesis. Cancer Res\u20082002; 62: 603\u20138."},{"key":"2022061623221409800_B37","doi-asserted-by":"crossref","unstructured":"Cao Y, Chen H, Zhou L, et al. Heterodimers of placenta growth factor\/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1\/KDR. J Biol Chem\u20081996; 271: 3154\u201362.","DOI":"10.1074\/jbc.271.6.3154"},{"key":"2022061623221409800_B38","doi-asserted-by":"crossref","unstructured":"DiSalvo J, Bayne ML, Conn G, et al. Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer. J Biol Chem\u20081995; 270: 7717\u201323.","DOI":"10.1074\/jbc.270.13.7717"},{"key":"2022061623221409800_B39","doi-asserted-by":"crossref","unstructured":"Grunewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell\u20082006; 124: 175\u201389.","DOI":"10.1016\/j.cell.2005.10.036"},{"key":"2022061623221409800_B40","doi-asserted-by":"crossref","unstructured":"Zentilin L, Tafuro S, Zacchigna S, et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood\u20082006; 107: 3546\u201354.","DOI":"10.1182\/blood-2005-08-3215"},{"key":"2022061623221409800_B41","doi-asserted-by":"crossref","unstructured":"Nozawa H, Chiu C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A\u20082006; 103: 12493\u20138.","DOI":"10.1073\/pnas.0601807103"},{"key":"2022061623221409800_B42","doi-asserted-by":"crossref","unstructured":"Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci U S A\u20081998; 95: 9349\u201354.","DOI":"10.1073\/pnas.95.16.9349"},{"key":"2022061623221409800_B43","doi-asserted-by":"crossref","unstructured":"Murakami M, Iwai S, Hiratsuka S, et al. Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes\/macrophages. Blood\u20082006; 108: 1849\u201356.","DOI":"10.1182\/blood-2006-04-016030"},{"key":"2022061623221409800_B44","doi-asserted-by":"crossref","unstructured":"Esser S, Lampugnani MG, Corada M, Dejana E, Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci\u20081998; 111: 1853\u201365.","DOI":"10.1242\/jcs.111.13.1853"},{"key":"2022061623221409800_B45","doi-asserted-by":"crossref","unstructured":"Oh SJ, Jeltsch MM, Birkenhager R, et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol\u20081997; 188: 96\u2013109.","DOI":"10.1006\/dbio.1997.8639"},{"key":"2022061623221409800_B46","doi-asserted-by":"crossref","unstructured":"Luttun A, Brusselmans K, Fukao H, et al. Loss of placental growth factor protects mice against vascular permeability in pathological conditions. Biochem Biophys Res Commun\u20082002; 295: 428\u201334.","DOI":"10.1016\/S0006-291X(02)00677-0"},{"key":"2022061623221409800_B47","doi-asserted-by":"crossref","unstructured":"Odorisio T, Schietroma C, Zaccaria ML, et al. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci\u20082002; 115: 2559\u201367.","DOI":"10.1242\/jcs.115.12.2559"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/22\/10840\/2575767\/10840.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/22\/10840\/2575767\/10840.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:03:21Z","timestamp":1655420601000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/22\/10840\/533747\/Placental-Growth-Factor-1-Attenuates-Vascular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,15]]},"references-count":47,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2007,11,15]]},"published-print":{"date-parts":[[2007,11,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-1034","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22371416.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371416","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496790.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496790","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,15]]}}}